Companies: 10,795·Total market cap: $144.5T
Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTANASDAQHealthcare● Active
$3.48
+$0.13(+3.88%)
Market Cap$31690237
P/E Ratio
52W High$5.07
52W Low$1.81
Overview

Lisata Therapeutics, Inc.(LSTA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LSTA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.17M$1.00M$0.00M$0.00M$0.00M
Cost of Revenue$0.15M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.02M$1.00M$0.00M$0.00M$0.00M
Gross Margin %(computed)14.12%100.00%
Operating Expenses
R&D Expenses$7.95M$11.33M$12.73M$43.46M$17.58M
G&A Expenses$10.43M$12.07M$12.97M$14.14M$11.47M
Total Operating Expenses$18.23M$23.41M$25.71M$57.60M$29.05M
Operating Income($18.21M)($22.41M)($25.71M)($57.60M)($29.05M)
Operating Margin %(computed)
Interest Income$0.81M$1.88M$2.72M$1.05M$0.15M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($17.55M)($20.78M)($23.17M)($56.70M)($28.97M)
Income Tax Expense($0.96M)($0.80M)($2.33M)($2.48M)($1.51M)
Net Income($16.59M)($19.98M)($20.84M)($54.23M)($27.47M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.91$-2.40$-2.58$-10.47$-7.45
Wtd Avg Shares8.69M8.33M8.07M5.18M3.69M
EBITDA($18.06M)($22.23M)($25.52M)($57.53M)($29.00M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Lisata Therapeutics, Inc.

关于Lisata Therapeutics, Inc.(LSTA)损益表

Lisata Therapeutics, Inc.(LSTA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LSTA实现营收$0.00B,毛利润$0.00B(毛利率14.12%),净利润($0.02B)(净利率-9756.47%)。

常见问题

LSTA · 4 问

Lisata Therapeutics, Inc.(LSTA)2025财年营收为$0.00B,同比down83.0%。

LSTA revenueLSTA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09